Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis Delta Virus Infection”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Testing effectiveness (Phase 2)Study completedNCT02430194
What this trial is testing

Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)

Who this might be right for
Chronic Hepatitis D Infection
Eiger BioPharmaceuticals 55
Testing effectiveness (Phase 2)Study completedNCT02765802
What this trial is testing

Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection

Who this might be right for
Hepatitis D, Chronic
EIT Pharma, Inc. 33
Testing effectiveness (Phase 2)WithdrawnNCT05953545
What this trial is testing

Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

Who this might be right for
Chronic Hepatitis Delta
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Large-scale testing (Phase 3)UnknownNCT05070364
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV

Who this might be right for
Hepatitis Delta Virus
Eiger BioPharmaceuticals 150
Testing effectiveness (Phase 2)Looking for participantsNCT07096193
What this trial is testing

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

Who this might be right for
Chronic Hepatitis Delta
Gilead Sciences 200
Testing effectiveness (Phase 2)Study completedNCT02511431
What this trial is testing

Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir

Who this might be right for
Hepatitis D
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 22
Testing effectiveness (Phase 2)Study completedNCT05861674
What this trial is testing

Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infection

Who this might be right for
Chronic Hepatitis Delta Virus Infection
Huahui Health 101
Testing effectiveness (Phase 2)Study completedNCT02637999
What this trial is testing

Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection

Who this might be right for
Chronic Hepatitis D Infection
Hepatera Ltd. 24
Testing effectiveness (Phase 2)WithdrawnNCT02968641
What this trial is testing

Lonafarnib With or Without Ritonavir in Patients With HDV

Who this might be right for
Chronic Delta Hepatitis
Eiger BioPharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00023322
What this trial is testing

Pegylated Interferon to Treat Chronic Hepatitis D

Who this might be right for
Hepatitis D
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 13
Not applicableNot Yet RecruitingNCT07727187
What this trial is testing

Hepatitis B Infection Surveillance

Who this might be right for
Chronic Hepatitis B Infection
Assistance Publique - Hôpitaux de Paris 1,360
Post-approval studies (Phase 4)Study completedNCT03356834
What this trial is testing

Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDF

Who this might be right for
Chronic Hepatitis B
Humanity and Health Research Centre 575
Not applicableLooking for participantsNCT06122285
What this trial is testing

Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)

Who this might be right for
Hepatitis D
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 100
Not applicableStudy completedNCT03908294
What this trial is testing

Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents

Who this might be right for
Glucose Metabolism DisordersLiver FibrosisHepatitis C
Johann Wolfgang Goethe University Hospital 46
Not applicableApproved For MarketingNCT06780579
What this trial is testing

Expanded Access for Bulevirtide

Who this might be right for
Chronic Hepatitis Delta Virus Infection
Gilead Sciences
Not applicableUnknownNCT06248580
What this trial is testing

Find HDV and Determine Its Status in Turkey

Who this might be right for
Chronic Hepatitis D InfectionFibrosis, LiverHepatocellular Carcinoma+2 more
Yaşar Bayındır, MD 20,000
Testing effectiveness (Phase 2)Study completedNCT05827146
What this trial is testing

Study of Hepalatide in Chronic Hepatitis D(CHD) Patients

Who this might be right for
Chronic Hepatitis D Infection
Shanghai HEP Pharmaceutical Co., Ltd. 23
Not applicableEnded earlyNCT01861444
What this trial is testing

An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)

Who this might be right for
Hepatitis D, Chronic
Hoffmann-La Roche 45
Testing effectiveness (Phase 2)Study completedNCT02430181
What this trial is testing

Lonafarnib With and Without Ritonavir in HDV (LOWR-1)

Who this might be right for
Chronic Hepatitis D Infection
Eiger BioPharmaceuticals 21
Large-scale testing (Phase 3)Study completedNCT00686790
What this trial is testing

Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)

Who this might be right for
Hepatitis D, ChronicHepatitis B, Chronic
Merck Sharp & Dohme LLC 68
Next Page